Jing Jing Xu
Director/Board Member at Hua Medicine (Shanghai) Co., Ltd.
Network origin in Jing Jing Xu first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Hua Medicine (Shanghai) Co., Ltd.
 Hua Medicine (Shanghai) Co., Ltd. BiotechnologyHealth Technology Hua Medicine (Shanghai) Co., Ltd. is a Chinese biotechnology company that focuses on the clinical needs of diabetic patients. The private company is based in Shanghai, China. The company has brought together high-end talents and scientific and technological resources to develop the world's first dorzagliatin (hms5552) for the treatment of type 2 diabetes. Hua Medicine has conducted two phase III clinical trials in 2019, targeting type 2 diabetes patients who have failed to treat the disease with other medications. The company plans to expand the advanced concepts of personalized therapy and management of diabetes to achieve effective control of diabetes and metabolic diseases and complications. The company was founded in 2011 by Li Chen, who has been the CEO since then.
3
| Private Company | Biotechnology | 3 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Jing Jing Xu via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Roche Pharmaceuticals, Inc.
 Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
China Life Sciences Access Fund LP
 China Life Sciences Access Fund LP Investment ManagersFinance China Life Sciences Access Fund LP is a venture capital fund that operates in the life sciences industry. The private company is based in George Town, Cayman Islands. | Investment Managers | Corporate Officer/Principal | |
| Tongji University | College/University | Corporate Officer/Principal | |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Corporate Officer/Principal | |
Peking University
 Peking University Other Consumer ServicesConsumer Services Peking University provides post-secondary education services. It offers undergraduate and graduate courses. It provides courses such as basic and applied sciences, social sciences and the humanities, sciences of medicine, management, and education. The company was founded by JiaNai Sun in 1898 and is headquartered in Beijing, China. | College/University | Undergraduate Degree | |
| Iowa State University | College/University | Doctorate Degree | |
| Zhengzhou University | College/University | Undergraduate Degree | |
| Université Catholique de Louvain | College/University | Doctorate Degree | |
| Roche (China) Co. Ltd. | Chief Tech/Sci/R&D Officer | ||
Neusoft Medical Systems Co., Ltd.
 Neusoft Medical Systems Co., Ltd. Medical SpecialtiesHealth Technology Neusoft Medical Systems Co., Ltd. engages in the research, development, manufacturing, and sale of large-scale medical diagnosis and treatment equipment and solutions as well as the provision of related services. Its products include computed tomography systems, magnetic resonance imaging systems, digital subtraction angiography systems, ultrasonic diagnostic equipment, positron emission tomography equipment, radiotherapy products, as well as in vitro diagnostic equipment and reagents. The company was founded on March 6, 1998 and is headquartered in Shenyang, China. | Medical Specialties | Director/Board Member | |
| SHANGHAI HILE BIO-TECHNOLOGY CO., LTD. | Pharmaceuticals: Major | Director/Board Member | |
Coland Pharmaceutical Co., Ltd.
 Coland Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Coland Pharmaceutical is a specialty pharmaceutical company focusing on marketing branded products and developing solid pipelines through collaboration with leading institutes. Its main interests are in the dedicated therapeutic areas Hepatitis, Immunology, Oncology, and other niche areas. Coland was started its sales operation in 2005. Daiding (Adefovir), a first-to-market generic that treats HBV was launched in 2005. With effective promotion, and brand building, Daiding achieved great success and gained the leading position in China. Its goal is to become a leading specialty pharmaceutical company in China with strong sales and marketing capabilities and solid product pipelines. The company was founded in 2003 and is headquartered in Shanghai, China. | Pharmaceuticals: Major | Director/Board Member | |
| COLAND HOLDINGS LIMITED | Pharmaceuticals: Major | Director/Board Member | |
| HUA MEDICINE (SHANGHAI) LTD. | Pharmaceuticals: Major | Founder Director/Board Member | |
| INNOVENT BIOLOGICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Sino-American Pharmaceutical Professionals Association | President | ||
| ADAGENE INC. | Pharmaceuticals: Major | Director/Board Member | |
6 Dimensions Capital
 6 Dimensions Capital Investment ManagersFinance 6 Dimensions Capital is an independent private equity firm headquartered in China. The firm was founded in 2017. | Investment Managers | Chief Executive Officer Private Equity Investor | |
| NEUSOFT XIKANG HOLDINGS INC. | Data Processing Services | Director/Board Member | |
Fog Pharmaceuticals, Inc.
 Fog Pharmaceuticals, Inc. BiotechnologyHealth Technology Fog Pharmaceuticals, Inc. develops pharmaceutical products. It discovers and develops cell-penetrating miniproteins (CPMPs), which are specifically designed to target cancer-causing proteins inside cancer cells and neutralize them. The company was founded by Gregory L. Verdine, WeiQing Zhou and David Philip Lane and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
TenNor Therapeutics Suzhou Ltd.
 TenNor Therapeutics Suzhou Ltd. Pharmaceuticals: GenericHealth Technology TenNor Therapeutics Suzhou Ltd. manufactures pharmaceutical products. It specializes in research and development of new drugs for the treatment of digestive diseases caused by pathogens, including those resistant to available antibiotics. The company was founded by Zhen Kun Ma in 2013 and is headquartered in Suzhou, China. | Pharmaceuticals: Generic | Director/Board Member | |
| CSTONE PHARMACEUTICALS | Pharmaceuticals: Major | Director/Board Member | |
Engine Biosciences Pte Ltd.
 Engine Biosciences Pte Ltd. BiotechnologyHealth Technology Engine Biosciences Pte Ltd. develops novel combinations of genes and drugs for therapeutic and industrial purposes. The company was founded by Timothy Lu and Jeffrey Lu and is headquartered in Singapore. | Biotechnology | Director/Board Member | |
Tengsheng Boyao Pharmaceutical Technology Shanghai Co., Ltd.
 Tengsheng Boyao Pharmaceutical Technology Shanghai Co., Ltd. Pharmaceuticals: MajorHealth Technology Tengsheng Boyao Pharmaceutical Technology Shanghai Co., Ltd. engages in research and development of medical technology. The company was founded by Zhi Hong on April 19, 2018 and is headquartered in Shanghai, China. | Pharmaceuticals: Major | Director/Board Member | |
Tongrun Biomedicine (Shanghai) Co., Ltd.
 Tongrun Biomedicine (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology Tongrun Biomedicine (Shanghai) Co., Ltd. develops tumor immunotherapy drugs. The company is based in Shanghai, China. | Pharmaceuticals: Major | Chairman | |
| 111, INC. | Medical Distributors | Director/Board Member | |
| Hua Medicine Technology (Hong Kong) Ltd. | Director/Board Member Director/Board Member | ||
| FIL Capital Management (Hong Kong) Ltd. | Corporate Officer/Principal | ||
| Roche R & D Center China Co. Ltd. | Chief Tech/Sci/R&D Officer | ||
| OCUMENSION THERAPEUTICS | Pharmaceuticals: Major | Chairman | |
Cutia Therapeutics (Shanghai) Co., Ltd.
 Cutia Therapeutics (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Cutia Therapeutics, Cutia Therapeutics (Shanghai) Co., Ltd. develops therapeutics to treat severe facial acne vulgaris. The company is based in Shanghai, China. The Chinese company was founded in 2019. The CEO is Le Le Zhang. | Pharmaceuticals: Major | Chairman | |
| CUTIA THERAPEUTICS | Pharmaceuticals: Major | Chairman | |
| East China Normal University | College/University | Corporate Officer/Principal |
Statistics
International
| China | 25 |
| United States | 6 |
| Hong Kong | 3 |
| Cayman Islands | 2 |
| Belgium | 2 |
Sectoral
| Health Technology | 18 |
| Consumer Services | 7 |
| Finance | 4 |
| Commercial Services | 2 |
| Technology Services | 2 |
Operational
| Director/Board Member | 24 |
| Corporate Officer/Principal | 7 |
| Chairman | 5 |
| Chief Executive Officer | 3 |
| Founder | 3 |
Most connected contacts
| Insiders | |
|---|---|
| Lian Yong Chen | 24 |
| Li Chen | 14 |
| Er Dong Hua | 3 |
- Stock Market
- Insiders
- Jing Jing Xu
- Company connections
